|
|
|
|
LEADER |
02623nam a2200373 u 4500 |
001 |
EB001839604 |
003 |
EBX01000000000000001003593 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
180702 r ||| eng |
100 |
1 |
|
|a Sarria-Santamera, Antonio
|
245 |
0 |
0 |
|a Percutaneous myocardial laser revascularization and transmyocardial laser revascularization
|h Elektronische Ressource
|c prepared for Agency for Healthcare Research and Quality, US Department of Health and Human Services ; prepared by the Duke Center for Clinical Health Policy Research and Evidence-based Practice Center ; Antonio Sarria-Santamera, Lawrence Liao, Ayn Huntington, David B. Matchar
|
260 |
|
|
|a Rockville, Maryland
|b Agency for Healthcare Research and Quality
|c 2004, June 22, 2004
|
300 |
|
|
|a 1 PDF file (132 pages)
|
505 |
0 |
|
|a Includes bibliographical references
|
653 |
|
|
|a United States
|
653 |
|
|
|a Myocardial Revascularization
|
653 |
|
|
|a Treatment Outcome
|
653 |
|
|
|a Angina Pectoris / therapy
|
653 |
|
|
|a Laser Therapy
|
653 |
|
|
|a Myocardial Ischemia / surgery
|
653 |
|
|
|a Coronary Artery Disease / therapy
|
700 |
1 |
|
|a Liao, Lawrence
|e [author]
|
700 |
1 |
|
|a Huntington, Ayn
|e [author]
|
700 |
1 |
|
|a Matchar, David B.
|e [author]
|
710 |
2 |
|
|a United States
|b Agency for Healthcare Research and Quality
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a Technology assessment
|
500 |
|
|
|a Title from PDF title page
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK285179
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 700
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a The Agency for Healthcare Research and Quality (AHRQ), on behalf of the Centers for Medicare and Medicaid Services (CMS), has requested a technology assessment on transmyocardial laser revascularization (TMR) and percutaneous myocardial laser revascularization (PMR) in preparation for a Medicare Coverage Advisory Committee meeting on this topic. The specific aims of this technology assessment are as follows: 1. Provide a summary and description of the technology.2. Review the peer-reviewed clinical literature on the outcomes associated with the use of: 1.1. TMR as a stand-alone procedure; 1.2. TMR used together with coronary artery bypass grafting (CABG);1.3. PMR.3. Review of available information on clinical trials underway as a horizon scan for this technology. In addition, studies on the mechanism of action and the specific lasers used for each of the procedures were reviewed, and a description of those findings is included in this report
|